Microtissue system allows study of deadly lung disease
Idiopathic pulmonary fibrosis (IPF) is a deadly and rapidly progressing disease with no cure.
Nov 16, 2021
0
30
Idiopathic pulmonary fibrosis (IPF) is a deadly and rapidly progressing disease with no cure.
Nov 16, 2021
0
30
Lung immunity is essential to combat all pulmonary diseases, including COVID-19, pneumonia, lung cancer, asthma and COPD. Lung immunity differs from the systemic immunity which is the normal focus of biomedical investigations ...
Oct 5, 2021
0
123
An international team of scientists have created a three-dimensional (3-D) pancreatic cancer tumour model in the laboratory, combining a bioengineered matrix and patient-derived cells that could be used to develop and test ...
Sep 24, 2021
0
58
Using lab-created tissue to heal or replace damaged organs is one of the great visions for the future of medicine. Synthetic materials could be suitable as scaffolding for tissue because, unlike natural tissues, they remain ...
Jul 28, 2021
0
592
Scientists have created a three-dimensional (3-D) tumor model in the laboratory for ovarian cancer that could lead to improved understanding and treatment of the disease.
Oct 2, 2020
0
84
Researchers at Karolinska Institutet in Sweden have developed a new method for identifying compounds that prevent aging. The method is based on a new way of determining age in cultured human cells and is reported in a study ...
Apr 10, 2019
0
268
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...
May 23, 2013
0
0
Zebrafish larvae—tiny, transparent and fast-growing vertebrates—are widely used to study development and disease. However, visually examining the larvae for variations caused by drugs or genetic mutations is an imprecise, ...
Feb 13, 2013
0
0
Researchers have overcome a major challenge to treating brain diseases by engineering an experimental molecular therapy that crosses the blood-brain barrier to reverse neurological lysosomal storage disease in mice.
Feb 4, 2013
0
0
(Medical Xpress)—A group of researchers in Austria and Switzerland has for the first time proven that immune cells migrate along chemical concentration gradients. This process has long been assumed but never demonstrated ...